Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor-Reference-Cited by-同舟云学术

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Published:2016-06-03 Issue:26 Volume:7 Page:40690-40703
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Coleman Daniel J.¹,Van Hook Kathryn¹,King Carly J.¹²,Schwartzman Jacob¹,Lisac Robert¹,Urrutia Joshua¹,Sehrawat Archana¹,Woodward Josha¹,Wang Nicholas J.¹²,Gulati Roman³,Thomas George V.¹,Beer Tomasz M.¹,Gleave Martin⁴,Korkola James E.¹²,Gao Lina¹,Heiser Laura M.¹²,Alumkal Joshi J.¹

Affiliation:

1. OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, U.S.A

2. Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, U.S.A

3. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, U.S.A

4. The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells;Neoplasia;2024-11

2. Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer;Cancers;2022-07-31

3. Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation;Cell Death & Disease;2021-09

4. Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention;Current Research in Chemical Biology;2021

5. Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro;Molecular Cancer Therapeutics;2020-12-09